Respiratory disease
Conditions
Interventions
Group A youth group (18-44 years old):During induction of anesthesia, subjects in group A given 2mg midazolam intravenously.
group B middle-aged group (45-59 years old):During induction of anesthesia, subjects in group B given 2mg midazolam intravenously
Group C Young and old (60~74 years old):During induction of anesthesia, subjects in group C was given 1mg midazolam intravenously.
group D elderly group (75-89 years old):During induction of anesthesia, subjects in group D was not given midazolam intravenously.
Sponsors
Yan'an Hospital of Kunming City
Eligibility
Sex/Gender
All
Age
18 Years to 89 Years
Inclusion criteria
Inclusion criteria: The patients who underwent painless fiberoptic bronchoscopy were of all genders and aged 18-89 years, with ASA grades I to III.
Exclusion criteria
Exclusion criteria: The patients examined were of all genders and aged 18-89 years old, with ASA grades I to III. Exclusion criteria: Patients with a history of severe hepatic and renal insufficiency, respiratory failure and cardiac insufficiency; Patients with bradycardia or sick sinus syndrome at rest before operation; Failure to maintain blood oxygen during examination and examination; Abuse or long-term use of narcotic, sedative, or analgesic drugs, and have a history of mental illness; Check for more than 30 minutes or unable to communicate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The sufentanil dose; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate, mean arterial pressure, pulse oxygen saturation and end expiratory carbon dioxide pressure were measured at each time point;Time of examination, time to wake up, adverse reactions;The degree of coughing reaction; | — |
Countries
China
Contacts
Public ContactYang Maiqiao
Yan'an Hospital of Kunming City
Outcome results
None listed